Product Wastage Documentation Requirements and Reporting: Using JW Modifier

by  Christine Woolstenhulme, CPC, CMRS, QCC, QMCS
November 28th, 2016

When using the JW modifier for Part B drug claims for discarded drugs and biologicals, any amount of wasted material should be clearly documented in the medical record with the following information:  

Medicare contractors may also require providers to report discarded amounts of products such as skin substitutes on a separate claim line item by attaching the JW modifier. If reporting skin grafts or substitutes, be sure to report the manufacturer’s serial/lot/batch or other unit identification number of graft material.

Reminder: The JW modifier is required for use on all claims with discarded Part B drugs and biologicals as of January 1st, 2017. Also, effective January 1st, 2017, providers must document the discarded drugs or biologicals in the patient's medical record.

It is also important to note the following:


Product Wastage Documentation Requirements and Reporting: Using JW Modifier. (2016, November 28). Find-A-Code Articles. Retrieved from

© InnoviHealth Systems Inc

Article Tags  (click on a tag to see related articles)

Publish this Article on your Website, Blog or Newsletter

This article is available for publishing on websites, blogs, and newsletters. The article must be published in its entirety - all links must be active. If you would like to publish this article, please contact us and let us know where you will be publishing it. The easiest way to get the text of the article is to highlight and copy. Or use your browser's "View Source" option to capture the HTML formatted code.

If you would like a specific article written on a medical coding and billing topic, please Contact Us.


innoviHealth Systems, Inc.
62 East 300 North
Spanish Fork, UT 84660
Phone: 801-770-4203 (8-5 Mountain)
free demo
request yours today
free subscription
for any budget

Thank you for choosing Find-A-Code, please Sign In to remove ads.